Nitric oxide status in patients with chronic kidney disease

Indian Journal of Nephrology

Volumn 25, Issue 5, 2015, Pages 287-291

  Reddy, Y S ^a   Kiranmayi, V S ^a   Bitla, A R ^a   Krishna, G S ^a   Srinivasa Rao, P V L N ^a   Sivakumar, V ^a  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asymmetric dimethyl arginine; chronic kidney disease; citrulline; endothelial dysfunction; nitric oxide

Indexed keywords

ARGININE; CITRULLINE; CREATININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRITE; UREA;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; MALE; MORBIDITY; UREA BLOOD LEVEL;

EID: 84941629666     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.147376     Document Type: Article

References (26)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-65
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006; 17: 2034-47
3. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007; 116: 85-97
4. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-92
5. Errakonda PR, Paladugu R, Bitla AR, Musturu SM, Lakshman J, Pemmaraju SR, et al. Effect of a single hemodialysis session on endothelial dysfunction. J Nephrol 2011; 24: 83-90
6. Wever R, Boer P, Hijmering M, Stroes E, Verhaar M, Kastelein J, et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 1999; 19: 1168-72
7. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 2008; 294: F1-9
8. Kielstein JT, Böger RH, Bode-Boger SM, Frölich JC, Haller H, Ritz E, et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 2002; 13: 170-6
9. Saran R, Novak JE, Desai A, Abdulhayoglu E, Warren JS, Bustami R, et al. Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): A pilot study. Nephrol Dial Transplant 2003; 18: 2415-20
10. Martens CR, Edwards DG. Peripheral vascular dysfunction in chronic kidney disease. Cardiol Res Pract 2011; 2011: 267257
11. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
13. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-3
14. Rajendra W. High performance liquid chromatographic determination of amino acids in biological samples by precolumn derivation with O-phthaldialdehyde. J Liq Chromatogr 1987; 10: 941-55
15. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000; 83: 205-9
16. Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 2000; 58: 1261-6
17. Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, et al. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 2006; 17: 2176-83
18. Cooke JP. Asymmetrical dimethylarginine: The Uber marker?. Circulation 2004; 109: 1813-8
19. Dobrian AD. ADMA and NOS regulation in chronic renal disease: Beyond the old rivalry for l-arginine. Kidney Int 2012; 81: 722-4
20. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 2001; 358: 2113-7
21. Baylis C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2006; 2: 209-20
22. Duranton F, Lundin U, Gayrard N, Mischak H, Aparicio M, Mourad G, et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. Clin J Am Soc Nephrol 2014; 9: 37-45
23. Lin YJ, Hsu CN, Lo MH, Huang CF, Chien SJ, Tain YL. High citrulline-to-arginine ratio associated with blood pressure abnormalities in children with early chronic kidney disease. Circ J 2013; 77: 181-7
24. Lutgens L, Lambin P. Biomarkers for radiation-induced small bowel epithelial damage: An emerging role for plasma Citrulline. World J Gastroenterol 2007; 13: 3033-42
25. Ware LB, Magarik JA, Wickersham N, Cunningham G, Rice TW, Christman BW, et al. Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis. Crit Care 2013; 17: R10
26. Böger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95: 2068-74